Mainak Banerjee

Kolkata, WB, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

Blood glucose monitoring in stable small-for-gestational-age infants below 3rd percentile versus 3rd-10th percentiles on INTERGROWTH-21st charts: A quasi-randomized controlled trial.

Blood glucose monitoring in stable small-for-gestational-age infants below 3rd percentile versus 3rd-10th percentiles on INTERGROWTH-21st charts: A quasi-randomized controlled trial.

Journal: Journal of neonatal-perinatal medicine
Published: June 17, 2026

Prepregnancy GLP-1 Receptor Agonist Use: Unaccounted Pretreatment BMI May Distort Obstetric Outcome Signals in Real-World Studies.

Prepregnancy GLP-1 Receptor Agonist Use: Unaccounted Pretreatment BMI May Distort Obstetric Outcome Signals in Real-World Studies.

Journal: Obesity (Silver Spring, Md.)
Published: May 30, 2026

Combined use of SGLT2 inhibitor and GLP-1 receptor agonist versus either monotherapy for cardiorenal Outcomes: an exploratory network meta-analysis of 16 randomized trials.

Combined use of SGLT2 inhibitor and GLP-1 receptor agonist versus either monotherapy for cardiorenal Outcomes: an exploratory network meta-analysis of 16 randomized trials.

Journal: Endocrine
Published: May 03, 2026

Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis.

Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta-Analysis.

Journal: Endocrinology, diabetes & metabolism
Published: April 22, 2026

Pre-Pregnancy GLP-1 Receptor Agonist or Tirzepatide Use and Gestational Diabetes Risk: Evaluating Pharmacodynamic Carry-Over Versus Post-Discontinuation Metabolic Rebound in a Multinational Federated Cohort.

Pre-Pregnancy GLP-1 Receptor Agonist or Tirzepatide Use and Gestational Diabetes Risk: Evaluating Pharmacodynamic Carry-Over Versus Post-Discontinuation Metabolic Rebound in a Multinational Federated Cohort.

Journal: Diabetes, obesity & metabolism
Published: March 21, 2026

Major Adverse Liver Outcomes With Tirzepatide and Injectable Semaglutide in Adults With Overweight or Obesity and Type 2 Diabetes.

Major Adverse Liver Outcomes With Tirzepatide and Injectable Semaglutide in Adults With Overweight or Obesity and Type 2 Diabetes.

Journal: Obesity (Silver Spring, Md.)
Published: February 23, 2026

Combined Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) and Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Therapy to Restore Fertility in Patients With Obesity, Polycystic Ovary Syndrome, and Incident Type 2 Diabetes.

Combined Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) and Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Therapy to Restore Fertility in Patients With Obesity, Polycystic Ovary Syndrome, and Incident Type 2 Diabetes.

Journal: Cureus
Published: January 26, 2026

Influence of bisphosphonate pretreatment on bone mineral density gains and fracture outcomes with teriparatide: A systematic review and meta-analysis.

Influence of bisphosphonate pretreatment on bone mineral density gains and fracture outcomes with teriparatide: A systematic review and meta-analysis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: January 26, 2026

Female sexual dysfunction in type 1 diabetes: a systematic review and meta-analysis.

Female sexual dysfunction in type 1 diabetes: a systematic review and meta-analysis.

Journal: Endocrine
Published: January 12, 2026

Trabecular Bone Score and Bone Turnover Markers Unmask Early Skeletal Fragility in Children and Adolescents With Type 1 Diabetes.

Trabecular Bone Score and Bone Turnover Markers Unmask Early Skeletal Fragility in Children and Adolescents With Type 1 Diabetes.

Journal: AACE endocrinology and diabetes
Published: December 04, 2025

Graves' disease with normal or heterogeneous 99mTc uptake: insights into the atypical scintigraphy patterns.

Graves' disease with normal or heterogeneous 99mTc uptake: insights into the atypical scintigraphy patterns.

Journal: Archives of endocrinology and metabolism
Published: October 31, 2025

Efficacy of Osteoanabolic Agents in Type 2 Diabetes Mellitus: a Meta-analysis and Review of the Literature.

Efficacy of Osteoanabolic Agents in Type 2 Diabetes Mellitus: a Meta-analysis and Review of the Literature.

Journal: Current osteoporosis reports
Published: September 14, 2025
Showing 1-12 of 63

Last Updated: 09/26/2026